𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of [64Cu]-DOTA-anti-CD20 for targeted therapy

✍ Scribed by A. R. Jalilian; L. Mirsadeghi; Y. Yari-kamrani; P. Rowshanfarzad; M. Kamali-dehghan; M. Sabet

Publisher
Springer
Year
2007
Tongue
English
Weight
130 KB
Volume
274
Category
Article
ISSN
1588-2780

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mass spectral analyses of labile DOTA-NH
Mass spectral analyses of labile DOTA-NHS and heterogeneity determination of DOTA or DM1 conjugated anti-PSMA antibody for prostate cancer therapy
✍ Sharon X. Lu; Edward J. Takach; Marjorie Solomon; Qing Zhu; Say-Jong Law; Frank πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 232 KB

Prostate specific membrane antigen (PSMA) is a well-characterized glycoprotein overexpressed on the surface of prostate cancer cells. The novel radiopharmaceutical 1,4,7,10-tetraazacyclododecane-N,N 0 ,N 00 ,N 000 -tetraacetic acid (DOTA) radiolabeled with Yttrium ( 90 Y) or Indium ( 111 In) conjuga